Medicinova Inc (MNOV) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MNOV Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Medicinova Inc funds operations, investments, and shareholder returns.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-4.90
Depreciation & amortization0.01
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.37
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.58
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Amortization Of Premium Discount On Investment Securities Convertible Notes And Debt Discount And Issuance Costs-
Impairment Charge On Investment Securities-
Impairment Of Sublease-
Amortization Of Deferred Revenue-
Deferred Revenue Period Increase Decrease-
Increase Decrease In Accounts Payable Accrued Expenses And Other Current Liabilities-0.74
Increase Decrease In Receivables Prepaid Deferred Expense And Other Assets-
Noncash Lease Expense-
Increase Decrease In Operating Lease Liability-0.05
Income taxes0.00
Gain (Loss) on Sale of Investments0.00
Increase (Decrease) in Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Recognition of Deferred Revenue0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.30
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.02
Discontinued operations0.00
Net Cash flow from Operating Activities-5.39
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Payments for (Proceeds from) Investments0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Disposal Of Investments-
Increase (Decrease) of Restricted Investments0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Proceeds from Divestiture of Interest in Joint Venture0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.01
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Auction Rate Securities Proceeds-
Proceeds From Conversion Of Convertible Notes-
Repayment Auction Rate Securities-
Proceeds From Ars Loan-
Repayments Of Ars Loan-
Proceeds Or Payments For Issuance Or Repurchase Of Common Stock Net-
Proceeds From Common Stock Option And Warrant Exercises-
Proceeds From Issuance Of Common Stock Exercise Of Common Stock Options And Warrants Net Of Issuance Costs-
Proceeds From Issuance Of Common Stock Exercise Of Common Stock Options-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-5.40
Total Cash Flow-5.39
4 historic quarters locked

Sign in to unlock the full Medicinova Inc cash flow history.

About Medicinova Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-349323

Figures are derived from filed reports and may be restated. Historical data is subject to revision.